*The iLIVE medication optimisation trial*
- Conditions
- patienten met een levensverwachting van 6 maanden of minder, ongeacht de aandoeningChronic diseasewith a life expectancy of 6 months or less
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 110
Patient:
1. Patient is 18 years or over and provides informed consent to participate.
2. The patient is aware that recovering from his/her disease is unlikely, as
assessed by the attending physician.
3. The patient agrees to participate in the iLIVE cohort study.
4. The attending physician would not be surprised if the patient were to die
within 6 months (*Surprise question*).
5. If the physician is uncertain about the surprise question, the patient is
eligible if presenting with at least one SPICT indicator.
Relative:
Relatives of included patients are asked to participate if they are:
1. 18 years or over and provide informed consent to participate; aware that it
is unlikely that the patient will recover from his/her disease;
2. capable of filling in a questionnaire in the country*s main language or in
English.
Patient:
1. The patient is incapable of filling in a questionnaire in the country*s main
language or in English (patients may be supported by relatives when filling in
the questionnaire).
2. The attending physician makes the decision that the patient should not be
included in the study due to e.g. illness burden, fast deterioration or
imminent death, lack of trusting relationship with the physician.
Relative:
Relatives are not eligible if they are incapable of filling in a questionnaire
in the country*s main language or in English. No more than one relative per
patient will be included.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Patients* quality of life four weeks after baseline assessment as measured by<br /><br>the EORTC QLQ-C15-PAL questionnaire, quality of life question. </p><br>
- Secondary Outcome Measures
Name Time Method